Noreva Pharma SAS Sustainability Profile
Noreva Pharma SAS, a prominent player in the pharmaceutical industry, is headquartered in France and operates extensively across Europe and beyond. Founded in 2003, the company has established itself as a leader in dermatological solutions, focusing on innovative treatments for skin conditions. Noreva Pharma is renowned for its unique range of products, including dermatological treatments and skincare lines that cater to various skin types and concerns. Their commitment to research and development has led to significant advancements in the field, positioning them as a trusted name among healthcare professionals and consumers alike. With a strong market presence and a reputation for quality, Noreva Pharma continues to achieve notable milestones, reinforcing its status as a key contributor to the pharmaceutical landscape.
DitchCarbon Score
How does Noreva Pharma SAS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Noreva Pharma SAS's score of 26 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Noreva Pharma SAS's reported carbon emissions
Noreva Pharma SAS, headquartered in France, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). As of now, Noreva Pharma SAS does not inherit emissions data from a parent company or related organisation, indicating that their climate strategy and emissions reporting are independent. Without specific emissions data or reduction commitments, it is unclear how the company is addressing its carbon footprint or contributing to broader climate goals within the pharmaceutical industry.
How Carbon Intensive is Noreva Pharma SAS's Industry?
How Carbon Intensive is Noreva Pharma SAS's Location?
Noreva Pharma SAS's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Noreva Pharma SAS has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
